The Prevention and Treatment of Intestinal Failure-associated Liver Disease in Neonates and Children

Surgical Clinics of North America

Volumn 91, Issue 3, 2011, Pages 543-563

  Nehra, Deepika ^a   Fallon, Erica M ^a   Puder, Mark ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Children; Cholestasis; Intestinal failure; Liver disease; Neonate; Parenteral nutrition; Short bowel syndrome

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIOXIDANT; BILIRUBIN GLUCURONIDE; CIPROFLOXACIN; CLINOLEIC; ENDOTOXIN; FISH OIL; GAMMA GLUTAMYLTRANSFERASE; GENTAMICIN; LINOLEIC ACID; LIPID EMULSION; LIPOFUNDIN; OMEGAVEN; POLYUNSATURATED FATTY ACID; PROTEIN HYDROLYSATE; TAURINE; URSODEOXYCHOLIC ACID; VANCOMYCIN; ZINC;

BACTERIAL OVERGROWTH; BLOODSTREAM INFECTION; CATHETER; CLINICAL FEATURE; DEHYDRATION; DIFFERENTIAL DIAGNOSIS; ENTERIC FEEDING; GASTROSTOMY; HEPATOBILIARY DISEASE; HUMAN; INTESTINAL FAILURE ASSOCIATED LIVER DISEASE; JEJUNOSTOMY TUBE; LABORATORY TEST; LIVER AMEBIASIS; LIVER BIOPSY; LIVER DISEASE; LIVER TRANSPLANTATION; MALNUTRITION; METABOLIC DISORDER; NUTRITIONAL REQUIREMENT; PARENTERAL NUTRITION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SEPSIS; SHORT BOWEL SYNDROME; UNITED STATES;

ENTERAL NUTRITION; HUMANS; INTESTINES; LIVER DISEASES; LIVER TRANSPLANTATION; MALABSORPTION SYNDROMES; PARENTERAL NUTRITION; PROGNOSIS; RISK FACTORS; SHORT BOWEL SYNDROME;

EID: 79957551659     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2011.02.003     Document Type: Review

References (159)

1. Goulet O., Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology 2006, 130(2 Suppl 1):S16-S28.
2. Duro D., Kamin D., Duggan C. Overview of pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2008, 47(Suppl 1):S33-S36.
3. Wilmore D.W., Dudrick S.J. Growth and development of an infant receiving all nutrients exclusively by vein. JAMA 1968, 203(10):860-864.
4. Ching Y.A., Gura K., Modi B., et al. Pediatric intestinal failure: nutrition, pharmacologic, and surgical approaches. Nutr Clin Pract 2007, 22(6):653-663.
5. Btaiche I.F., Khalidi N. Parenteral nutrition-associated liver complications in children. Pharmacotherapy 2002, 22(2):188-211.
6. Buchman A. Total parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr 2002, 26(Suppl 5):S43-S48.
7. Kelly D.A. Liver complications of pediatric parenteral nutrition-epidemiology. Nutrition 1998, 14(1):153-157.
8. Quiros-Tejeira R.E., Ament M.E., Reyen L., et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr 2004, 145(2):157-163.
9. Willis T.C., Carter B.A., Rogers S.P., et al. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 2010, 34(1):32-37.
10. Chan S., McCowen K.C., Bistrian B.R., et al. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery 1999, 126(1):28-34.
11. Diamanti A., Basso M.S., Castro M., et al. Prevalence of life-threatening complications in pediatric patients affected by intestinal failure. Transplant Proc 2007, 39(5):1632-1633.
12. Andorsky D.J., Lund D.P., Lillehei C.W., et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001, 139(1):27-33.
13. Moss R.L., Amii L.A. New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis. Semin Pediatr Surg 1999, 8(3):140-147.
14. Beath S.V., Davies P., Papadopoulou A., et al. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg 1996, 31(4):604-606.
15. Christensen R.D., Henry E., Wiedmeier S.E., et al. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J Perinatol 2007, 27(5):284-290.
16. Beale E.F., Nelson R.M., Bucciarelli R.L., et al. Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics 1979, 64(3):342-347.
17. Kubota A., Okada A., Nezu R., et al. Hyperbilirubinemia in neonates associated with total parenteral nutrition. JPEN J Parenter Enteral Nutr 1988, 12(6):602-606.
18. Kaufman S.S., Pehlivanova M., Fennelly E.M., et al. Predicting liver failure in parenteral nutrition-dependent short bowel syndrome of infancy. J Pediatr 2010, 156(4). 580.e1-585.e1.
19. Wu P.A., Kerner J.A., Berquist W.E. Parenteral nutrition-associated cholestasis related to parental care. Nutr Clin Pract 2006, 21(3):291-295.
20. Zambrano E., El-Hennawy M., Ehrenkranz R.A., et al. Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases. Pediatr Dev Pathol 2004, 7(5):425-432.
21. Dahms B.B., Halpin T.C. Serial liver biopsies in parenteral nutrition-associated cholestasis of early infancy. Gastroenterology 1981, 81(1):136-144.
22. Fitzgibbons S.C., Jones B.A., Hull M.A., et al. Relationship between biopsy-proven parenteral nutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome. J Pediatr Surg 2010, 45(1):95-99. [discussion: 99].
23. Moss R.L., Das J.B., Raffensperger J.G. Total parenteral nutrition-associated cholestasis: clinical and histopathologic correlation. J Pediatr Surg 1993, 28(10):1270-1274. [discussion: 1274-5].
24. Wretlind A. Development of fat emulsions. JPEN J Parenter Enteral Nutr 1981, 5(3):230-235.
25. Edgren B., Wretlind A. The theoretical background of the intravenous nutrition with fat emulsions. Nutr Dieta Eur Rev Nutr Diet 1963, 13:364-386.
26. Schuberth O.W.A. Intravenous infusion of fat emulsions, phosphatides and emulsifying agents. Acta Chir Scand 1961, 13(Suppl):S278-S284.
27. Das U.N. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 2006, 1(4):420-439.
28. Chen W.J., Yeh S.L., Huang P.C. Effects of fat emulsions with different fatty acid composition on plasma and hepatic lipids in rats receiving total parenteral nutrition. Clin Nutr 1996, 15(1):24-28.
29. Aksnes J., Eide T.J., Nordstrand K. Lipid entrapment and cellular changes in the rat myocard, lung and liver after long-term parenteral nutrition with lipid emulsion. A light microscopic and ultrastructural study. APMIS 1996, 104(7-8):515-522.
30. Zaman N., Tam Y.K., Jewell L.D., et al. Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos 1997, 18(9):803-819.
31. Clayton P.T., Whitfield P., Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 1998, 14(1):158-164.
32. Thomas-Gibson S., Jawhari A., Atlan P., et al. Safe and efficacious prolonged use of an olive oil-based lipid emulsion (ClinOleic) in chronic intestinal failure. Clin Nutr 2004, 23(4):697-703.
33. Palova S., Charvat J., Kvapil M. Comparison of soybean oil- and olive oil-based lipid emulsions on hepatobiliary function and serum triacylglycerols level during realimentation. J Int Med Res 2008, 36(3):587-593.
34. Fallon E.M., Le H.D., Puder M. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr Opin Organ Transplant 2010, 15(3):334-340.
35. Lee S., Gura K.M., Puder M. Omega-3 fatty acids and liver disease. Hepatology 2007, 45(4):841-845.
36. Prescott S.M. The effect of eicosapentaenoic acid on leukotriene B production by human neutrophils. J Biol Chem 1984, 259(12):7615-7621.
37. Camandola S., Leonarduzzi G., Musso T., et al. Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun 1996, 229(2):643-647.
38. Chen M.F., Lee Y.T., Hsu H.C., et al. Effects of dietary supplementation with fish oil on prostanoid metabolism during acute coronary occlusion with or without reperfusion in diet-induced hypercholesterolemic rabbits. Int J Cardiol 1992, 36(3):297-304.
39. Lee S., Gura K.M., Kim S., et al. Current clinical applications of omega-6 and omega-3 fatty acids. Nutr Clin Pract 2006, 21(4):323-341.
40. Alwayn I.P., Gura K., Nose V., et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res 2005, 57(3):445-452.
41. Grimminger F., Wahn H., Mayer K., et al. Impact of arachidonic versus eicosapentaenoic acid on exotonin-induced lung vascular leakage: relation to 4-series versus 5-series leukotriene generation. Am J Respir Crit Care Med 1997, 155(2):513-519.
42. Carter B.A., Shulman R.J. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol 2007, 4(5):277-287.
43. Carter B.A., Taylor O.A., Prendergast D.R., et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res 2007, 62(3):301-306.
44. Gura K.M., Parsons S.K., Bechard L.J., et al. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr 2005, 24(5):839-847.
45. Gura K.M., Duggan C.P., Collier S.B., et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006, 118(1):e197-e201.
46. Gura K.M., Lee S., Valim C., et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008, 121(3):e678-e686.
47. Puder M., Valim C., Meisel J.A., et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009, 250(3):395-402.
48. de Meijer V.E., Gura K.M., Le H.D., et al. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr 2009, 33(5):541-547.
49. de Meijer V.E., Le H.D., Meisel J.A., et al. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr 2010, 50(2):212-218.
50. de Meijer V.E., Gura K.M., Meisel J.A., et al. Parenteral fish oil as monotherapy for patients with parenteral nutrition-associated liver disease. Pediatr Surg Int 2009, 25(1):123-124.
51. Diamond I.R., Sterescu A., Pencharz P.B., et al. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009, 48(2):209-215.
52. Lee S.I., Valim C., Johnston P., et al. The impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res 2009, 66(6):698-703.
53. Calhoun A.W., Sullivan J.E. Omegaven for the treatment of parenteral nutrition associated liver disease: a case study. J Ky Med Assoc 2009, 107(2):55-57.
54. de Meijer V.E., Gura K.M., Meisel J.A., et al. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. Arch Surg 2010, 145(6):547-551.
55. Ekema G., Falchetti D., Boroni G., et al. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids). J Pediatr Surg 2008, 43(6):1191-1195.
56. Cheung H.M., Lam H.S., Tam Y.H., et al. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid. Clin Nutr 2009, 28(2):209-212.
57. Carlson S.E., Cooke R.J., Werkman S.H., et al. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids 1992, 27(11):901-907.
58. Carlson S.E., Werkman S.H., Peeples J.M., et al. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci U S A 1993, 90(3):1073-1077.
59. Carlson S.E., Werkman S.H., Tolley E.A. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am J Clin Nutr 1996, 63(5):687-697.
60. Le H.D., de Meijer V.E., Zurakowski D., et al. Parenteral fish oil as monotherapy improves lipid profiles in children with parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr 2010, 34(5):477-484.
61. Vanschoonbeek K., Feijge M.A., Paquay M., et al. Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation. Arterioscler Thromb Vasc Biol 2004, 24(9):1734-1740.
62. Mirtallo J., Canada T., Johnson D., et al. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr 2004, 28(6):S39-S70.
63. Cavicchi M., Beau P., Crenn P., et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000, 132(7):525-532.
64. Wessel J.J., Kocoshis S.A. Nutritional management of infants with short bowel syndrome. Semin Perinatol 2007, 31(2):104-111.
65. Colomb V., Jobert-Giraud A., Lacaille F., et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2000, 24(6):345-350.
66. Crawford M.A., Costeloe K., Ghebremeskel K., et al. The inadequacy of the essential fatty acid content of present preterm feeds. Eur J Pediatr 1998, 157(Suppl 1):S23-S27.
67. Innis S.M. Omega-3 Fatty acids and neural development to 2 years of age: do we know enough for dietary recommendations?. J Pediatr Gastroenterol Nutr 2009, 48(Suppl 1):S16-S24.
68. Pediatric nutrition handbook 2009, American Academy of Pediatrics, Elk Grove Village (IL). 6th edition. R.E. Kleinman (Ed.).
69. Le H.D., Fallon E.M., de Meijer V.E., et al. Innovative parenteral and enteral nutrition therapy for intestinal failure. Semin Pediatr Surg 2010, 19(1):27-34.
70. Chwals W.J. The metabolic response to surgery in neonates. Curr Opin Pediatr 1994, 6:330-340.
71. Schiller W.R. Burn management in children. Pediatr Ann 1996, 25:434-438.
72. Collier S., Crouch J., Hendricks K., et al. Use of cyclic parenteral nutrition in infants less than 6 months of age. Nutr Clin Pract 1994, 9(2):65-68.
73. Takehara H., Hino M., Kameoka K., et al. A new method of total parenteral nutrition for surgical neonates: it is possible that cyclic TPN prevents intrahepatic cholestasis. Tokushima J Exp Med 1990, 37(3-4):97-102.
74. Jensen A.R., Goldin A.B., Koopmeiners J.S., et al. The association of cyclic nutrition and decreased incidence of cholestatic liver disease in patients with gastroschisis. J Pediatr Surg 2009, 44:183-189.
75. Sjoberg P., Bondesson U., Sedin G., et al. Dispositions of di- and mono-(2-ethylhexyl) phthalate in newborn infants subjected to exchange transfusions. Eur J Clin Invest 1985, 15(6):430-436.
76. Von Rettberg H., Hannman T., Subotic U., et al. Use of di(2-ethylhexyl)phthalate containing infusion systems increases the risk for cholestasis. Pediatrics 2009, 124:710-716.
77. Silva M.J., Barr D.B., Reidy J.A., et al. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect 2004, 112:331-333.
78. Bohrer D., Cicero do Nascimento P., Binotto R., et al. Contribution of the raw material to the aluminum contamination in parenterals. JPEN J Parenter Enteral Nutr 2002, 26:382-388.
79. Poole R.L., Hintz S.R., Mackenzie N.I., et al. Aluminum exposure from pediatric parenteral nutrition: meeting the new FDA regulation. JPEN J Parenter Enteral Nutr 2008, 32:242.
80. Aluminum in large and small volume parenterals used in total parenteral nutrition-FDA. Proposed rule. Fed Regist 1998, 63(2):176-185.
81. Day C.P., James O.F. Steatohepatitis: a tale of two "hits" ?. Gastroenterology 1998, 114(4):842-845.
82. Becvarova I., Saker K.E., Swecker W.S., et al. Peroxidative protection of parenteral admixture by d-alpha-tocopherol. Vet Ther 2005, 6(4):280-290.
83. Soden J.S., Devereaux M.W., Haas J.E., et al. Subcutaneous vitamin E ameliorates liver injury in an in vivo model of steatocholestasis. Hepatology 2007, 46(2):485-495.
84. Goulet O., Joly F., Corriol O., et al. Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transplant 2009, 14(3):256-261.
85. Sweeny D.J., Barnes S., Diasio R.B. Bile acid conjugation pattern in the isolated perfused rat liver during infusion of an amino acid formulation. JPEN J Parenter Enteral Nutr 1991, 15(3):303-306.
86. Yousef I.M., Tuchweber B., Vonk R.J., et al. Lithocholate cholestasis-sulfated glycolithocholate-induced intrahepatic cholestasis in rats. Gastroenterology 1981, 80:233-241.
87. Guertin F., Roy C.C., Lepage G., et al. Effect of taurine on total parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 1991, 15(3):247-251.
88. Cooper A., Betts J.M., Pereira G.R., et al. Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition. J Pediatr Surg 1984, 19(4):462-466.
89. Vinton N.E., Laidlaw S.A., Ament M.E., et al. Taurine concentrations in plasma, blood cells, and urine of children under-going long-term parenteral nutrition. Pediatrics 1987, 21:399-403.
90. Dahlstrom K.A., Ament M.E., Laidlaw S.A., et al. Plasma amino acid concentrations in children receiving long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 1988, 7:748-754.
91. Spencer A.U., Yu S., Tracy T.F., et al. Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine. JPEN J Parenter Enteral Nutr 2005, 29(5):337-343. [discussion: 343-4].
92. Cooke R.J., Whitington P.F., Kelts D. Effect of taurine supplementation on hepatic function during short-term parenteral nutrition in the premature infant. J Pediatr Gastroenterol Nutr 1984, 3(2):234-238.
93. Friel J.K., Gibson R.S., Peliowski A., et al. Serum zinc, copper, and selenium concentrations in preterm infants receiving enteral nutrition or parental nutrition supplemented with zinc and copper. J Pediatr 1984, 104(5):763-768.
94. Zlotkin S.H., Buchanan B.E. Meeting zinc and copper intake requirements in the parenterally fed preterm and full-term infant. J Pediatr 1983, 103(3):441-446.
95. Latimer J.S., McClain C.J., Sharp H.L. Clinical zinc deficiency during zinc-supplemented parenteral nutrition. J Pediatr 1980, 97(3):434-437.
96. Weber T.R., Sears N., Davies B., et al. Clinical spectrum of zinc deficiency in pediatric patients receiving total parenteral nutrition (TPN). J Pediatr Surg 1981, 16(3):236-240.
97. Goulet O. Short bowel syndrome in pediatric patients. Nutrition 1998, 14(10):784-787.
98. Jeejeebhoy K.N. Management of short bowel syndrome: avoidance of total parenteral nutrition. Gastroenterology 2006, 130(2 Suppl 1):S60-S66.
99. Perdikis D.A., Basson M.D. Basal nutrition promotes human intestinal epithelial (Caco-2) proliferation, brush border enzyme activity, and motility. Crit Care Med 1997, 25(1):159-165.
100. Parker P., Stroop S., Greene H. A controlled comparison of continuous versus intermittent feeding in the treatment of infants with intestinal disease. J Pediatr 1981, 99(3):360-364.
101. Zamir O., Nussbaum M.S., Bhadra S., et al. Effect of enteral feeding on hepatic steatosis induced by total parenteral nutrition. JPEN J Parenter Enteral Nutr 1994, 18(1):20-25.
102. Meehan J.J., Georgeson K.E. Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome. J Pediatr Surg 1997, 32(3):473-475.
103. Sondheimer J.M., Cadnapaphornchai M., Sontag M., et al. Predicting the duration of dependence on parenteral nutrition after neonatal intestinal resection. J Pediatr 1998, 132(1):80-84.
104. Javid P.J., Collier S., Richardson D., et al. The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants. J Pediatr Surg 2005, 40(6):1015-1018.
105. Pimenta H.P., Moreira M.E., Rocha A.D., et al. J Pediatr (Rio J) 2008, 84(5):423-427. [in English, Portuguese].
106. Playford R.J., Macdonald C.E., Johnson W.S. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. Am J Clin Nutr 2000, 72(1):5-14.
107. Xanthou M., Bines J., Walker W.A. Human milk and intestinal host defense in newborns: an update. Adv Pediatr 1995, 42:171-208.
108. Byrne T.A., Morrissey T.B., Nattakom T.V., et al. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr 1995, 19(4):296-302.
109. Stern L.E., Falcone R.A., Huang F., et al. Epidermal growth factor alters the bax:bcl-w ratio following massive small bowel resection. J Surg Res 2000, 91(1):38-42.
110. Cummins A.G., Thompson F.M. Effect of breast milk and weaning on epithelial growth of the small intestine in humans. Gut 2002, 51(5):748-754.
111. Bines J., Francis D., Hill D. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr 1998, 26(2):123-128.
112. Vanderhoof J.A. New and emerging therapies for short bowel syndrome in children. J Pediatr Gastroenterol Nutr 2004, 39(Suppl 3):S769-S771.
113. Vanderhoof J.A., Grandjean C.J., Kaufman S.S., et al. Effect of high percentage medium-chain triglyceride diet on mucosal adaptation following massive bowel resection in rats. JPEN J Parenter Enteral Nutr 1984, 8(6):685-689.
114. Kollman K.A., Lien E.L., Vanderhoof J.A. Dietary lipids influence intestinal adaptation after massive bowel resection. J Pediatr Gastroenterol Nutr 1999, 28(1):41-45.
115. Lai H.S., Chen W.J., Chen K.M., et al. Effects of monomeric and polymeric diets on small intestine following massive resection. Taiwan Yi Xue Hui Za Zhi 1989, 88(10):982-988.
116. Axelrod D., Kazmerski K., Iyer K. Pediatric enteral nutrition. JPEN J Parenter Enteral Nutr 2006, 30(Suppl 1):S21-S26.
117. Serrano M.S., Schmidt-Sommerfeld E. Nutrition support of infants with short bowel syndrome. Nutrition 2002, 18(11-12):966-970.
118. Spagnuolo M.I., Iorio R., Vegnente A., et al. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology 1996, 111(3):716-719.
119. Levine A., Maayan A., Shamir R., et al. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment. J Pediatr Endocrinol Metab 1999, 12(4):549-553.
120. Chen C.Y., Tsao P.N., Chen H.L., et al. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. J Pediatr 2004, 145(3):317-321.
121. Heubi J.E., Wiechmann D.A., Creutzinger V., et al. Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease. J Pediatr 2002, 141(2):237-242.
122. Teitelbaum D.H., Tracy T.F., Aouthmany M.M., et al. Use of cholecystokinin-octapeptide for the prevention of parenteral nutrition-associated cholestasis. Pediatrics 2005, 115(5):1332-1340.
123. Tsai S., Strouse P.J., Drongowski R.A., et al. Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease. J Pediatr Surg 2005, 40(1):263-267.
124. San Luis V.A., Btaiche I.F. Ursodiol in patients with parenteral nutrition-associated cholestasis. Ann Pharmacother 2007, 41(11):1867-1872.
125. Chang C.Y., Schiano T.D. Review article: drug hepatotoxicity. Aliment Pharmacol Ther 2007, 25(10):1135-1151.
126. de Abajo F.J., Montero D., Madurga M., et al. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol 2004, 58(1):71-80.
127. Chang C.C., Petrelli M., Tomashefski J.F., et al. Severe intrahepatic cholestasis caused by amiodarone toxicity after withdrawal of the drug: a case report and review of the literature. Arch Pathol Lab Med 1999, 123(3):251-256.
128. Stieger B., Fattinger K., Madon J., et al. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 2000, 118(2):422-430.
129. Larrey D., Erlinger S. Drug-induced cholestasis. Baillieres Clin Gastroenterol 1988, 2(2):423-452.
130. Zimmerman H.J., Lewis J.H. Drug-induced cholestasis. Med Toxicol 1987, 2(2):112-160.
131. Sondheimer J.M., Asturias E., Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 1998, 27(2):131-137.
132. O'Brien D.P., Nelson L.A., Kemp C.J., et al. Intestinal permeability and bacterial translocation are uncoupled after small bowel resection. J Pediatr Surg 2002, 37(3):390-394.
133. Fratino G., Molinari A.C., Mazzola C., et al. Prospective study of indwelling central venous catheter-related complications in children with broviac or clampless valved catheters. J Pediatr Hematol Oncol 2002, 24(8):657-661.
134. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002, 51(RR-10):1-29.
135. Lee D.H., Jung K.Y., Choi Y.H. Use of maximal sterile barrier precautions and/or antimicrobial-coated catheters to reduce the risk of central venous catheter-related bloodstream infection. Infect Control Hosp Epidemiol 2008, 29(10):947-950.
136. Chelliah A., Heydon K.H., Zaoutis T.E., et al. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Pediatr Infect Dis J 2007, 26(9):816-820.
137. Lorente L., Lecuona M., Ramos M.J., et al. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia. Clin Infect Dis 2008, 47(9):1171-1175.
138. Segarra-Newnham M., Martin-Cooper E.M. Antibiotic lock technique: a review of the literature. Ann Pharmacother 2005, 39(2):311-318.
139. Rackoff W.R., Weiman M., Jakobowski D., et al. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr 1995, 127(1):147-151.
140. Metcalf S.C., Chambers S.T., Pithie A.D. Use of ethanol locks to prevent recurrent central line sepsis. J Infect 2004, 49(1):20-22.
141. Broom J., Woods M., Allworth A., et al. Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial. Scand J Infect Dis 2008, 40(5):399-406.
142. Mouw E., Chessman K., Lesher A., et al. Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome. J Pediatr Surg 2008, 43(6):1025-1029.
143. Slobbe L., Doorduijn J.K., Lugtenburg P.J., et al. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One 2010, 5(5):e10840.
144. Sigalet D., Boctor D., Robertson M., et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg 2009, 19(6):348-353.
145. Vanderhoof J.A., Langnas A.N. Short-bowel syndrome in children and adults. Gastroenterology 1997, 113(5):1767-1778.
146. Freund H.R., Muggia-Sullam M., LaFrance R., et al. A possible beneficial effect of metronidazole in reducing TPN-associated liver function derangements. J Surg Res 1985, 38(4):356-363.
147. Drongowski R.A., Coran A.G. An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis. JPEN J Parenter Enteral Nutr 1989, 13(6):586-589.
148. Ginn-Pease M.E., Pantalos D., King D.R. TPN-associated hyperbilirubinemia: a common problem in newborn surgical patients. J Pediatr Surg 1985, 20(4):436-439.
149. Arsenault D.A., Potemkin A.K., Robinson E.M., et al. Surgical intervention in the setting of parenteral nutrition associated cholestasis may exacerbate liver injury. J Pediatr Surg 2011, 46(1):122-127.
150. Weizman Z., Schmueli A., Deckelbaum R.J. Continuous nasogastric drip elemental feeding. Alternative for prolonged parenteral nutrition in severe prolonged diarrhea. Am J Dis Child 1983, 137(3):253-255.
151. Bianchi A. Intestinal loop lengthening-a technique for increasing small intestinal length. J Pediatr Surg 1980, 15(2):145-151.
152. Bianchi A. Longitudinal intestinal lengthening and tailoring: results in 20 children. J R Soc Med 1997, 90(8):429-432.
153. Modi B.P., Javid P.J., Jaksic T., et al. First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications. J Am Coll Surg 2007, 204(3):365-371.
154. Kim H.B., Fauza D., Garza J., et al. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg 2003, 38(3):425-429.
155. Mazariegos G.V., Squires R.H., Sindhi R.K. Current perspectives on pediatric intestinal transplantation. Curr Gastroenterol Rep 2009, 11(3):226-233.
156. Goulet O., Kamin D. Intestinal failure, short bowel syndrome, and intestinal transplantation. Nutrition in pediatrics 2007, 641-662. BC Decker, Hamilton (ON). 4th edition. C. Duggan, J.B. Watkins, W.A. Walker (Eds.).
157. Horslen S.P., Sudan D.L., Iyer K.R., et al. Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome. Ann Surg 2002, 235(3):435-439.
158. Dell-Olio D., Beath S.V., de Ville de Goyet J., et al. Isolated liver transplant in infants with short bowel syndrome: insights into outcomes and prognostic factors. J Pediatr Gastroenterol Nutr 2009, 48(3):334-340.
159. Santra S., McKiernan P., Lander A., et al. Ischemic hepatitis is a risk factor for progression of liver disease associated with parenteral nutrition in intestinal failure. J Pediatr Gastroenterol Nutr 2008, 47(3):367-369.